➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Harvard Business School
McKesson
Baxter
Colorcon

Last Updated: October 23, 2021

DrugPatentWatch Database Preview

Lidocaine hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for lidocaine hydrochloride and what is the scope of patent protection?

Lidocaine hydrochloride is the generic ingredient in thirty-five branded drugs marketed by Akorn, Carlisle, Abbott, Abraxis Pharm, Am Regent, Aurobindo Pharma Ltd, B Braun Medical Inc, Bel Mar, Belmora Llc, Dell Labs, Elkins Sinn, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Huons, Intl Medication, Luitpold, Lyphomed, Miles, Mylan Labs Ltd, Spectra Mdcl Devices, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Baxter Hlthcare, B Braun, Pharmaton, Meridian Medcl Techn, Astrazeneca, Dentsply Pharm, Bionpharma Inc, Sagent Pharms Inc, Cosette, Watson Labs Inc, Wockhardt Bio Ag, Actavis Mid Atlantic, Lannett Co Inc, Hikma Pharms, Kendall Il, Paco, Teligent, Powder Pharms, and Pfizer, and is included in one hundred and two NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lidocaine hydrochloride has nineteen patent family members in ten countries.

There are twenty-nine drug master file entries for lidocaine hydrochloride. Forty suppliers are listed for this compound.

Summary for lidocaine hydrochloride
International Patents:19
US Patents:4
Tradenames:35
Applicants:43
NDAs:102
Drug Master File Entries: 29
Finished Product Suppliers / Packagers: 40
Raw Ingredient (Bulk) Api Vendors: 57
Clinical Trials: 1,486
Patent Applications: 5
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in lidocaine hydrochloride?lidocaine hydrochloride excipients list
DailyMed Link:lidocaine hydrochloride at DailyMed
Recent Clinical Trials for lidocaine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
VA Office of Research and DevelopmentPhase 3
The Foundation for Barnes-Jewish HospitalPhase 2
Stanford UniversityEarly Phase 1

See all lidocaine hydrochloride clinical trials

US Patents and Regulatory Information for lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer TERRAMYCIN lidocaine hydrochloride; oxytetracycline INJECTABLE;INJECTION 060567-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hospira LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 088330-001 May 17, 1984 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Bel Mar LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 080760-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hikma Pharms LIDOCAINE VISCOUS lidocaine hydrochloride SOLUTION;ORAL 088802-001 Apr 26, 1985 AT RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hospira LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER lidocaine hydrochloride INJECTABLE;INJECTION 088367-001 Jul 31, 1984 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 ⤷  Try it Free ⤷  Try it Free
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 ⤷  Try it Free ⤷  Try it Free
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 ⤷  Try it Free ⤷  Try it Free
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Harvard Business School
McKesson
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.